Investors Contact

We are committed to maintaining relationships with our investors, shareholders and persons interested in investor relations information. Contact us.

Mateusz Sagan
Chief Business Officer / Supervisory Board Member


Experienced Senior Executive Manager / Chief Business Officer at SDS Optic
MBA graduate from University of Central Lancashire Preston, UK
Experienced Leader and Executive Management, specialized in strategic management, sales management, start-ups in different countries and cultures. Strong financial, ethics and compliance background, with personal capabilities developed with Dale Carnagie and Franklin Covey programs.
Strong Leadership and Vision building expertise.
Polish National Sales Awards referee; Business Centre Club member, TEDx speaker

Ownership structure

As of April 2019, Share Capital of SDS Optic represents 76.860 shares valued 3.843.000,00 PLN, each share valued at 50,00PLN. SDS Optic ownership structure consists of capital belong to: Magdalena Staniszewska, SDS Optonic LLC, Innoventure, Polish Entrerpreneurs Foundation.

Magdalena Staniszewska, PhD, DSc
Co-Founder, Chief Science Officer

235 500 shares valued 235.500,00 PLN – 6,1% in Share Capital

SDS Optonic LLC
a Special Purpose Vehicle (SPV), controlled and managed by Marcin Staniszewski, Co-Founder and CEO

2 400 000 shares valued 2.400.000,00 PLN – 62,5%

Majority of SDS Optonic LLC shares belong to Marcin Staniszewski. Remaining part of SDS Optonic LLC shares belong to 4 Business Angels, who invested at early startup phase.

INNOventure – venture capital fund from Cracov, Poland

INNOventure helps scientists, inventors and entrepreneurs develop business projects based on the results of research and development. INNOventure creates companies together with scientists, research institutes and investors. As a shareholder INNOventure provides not only financial capital, but also broad support in building valuable businesses

490 750 shares valued 407.500,00 PLN – 10,6%

Polska Fundacja Przedsiębiorczości

Polish Entrepreneurs Foundation (PFP) – seed fund from Szczecin, Poland

POMERANUS SEED is managed by Polish Entrepreneurs Foundation, one of the largest SME support organization in Poland.
The fund was launched in 2010 and actively invests in polish technology startups.
Initial capitalization was 18 mln zl. Currently the fund invests money coming from exits.

800 000 shares valued 800.000,00 PLN – 20,8%

Media about SDS Optic

SDS Optic is committed to providing the media with timely and accurate information. This section offers key resources for journalists, editors and other media professionals. Here you can read more about progress, and explore our recent announcements and resources.

Lubelscy naukowcy: Dzięki tej metodzie szybciej wykryjemy raka piersi

Unikalny projekt naukowców z Lublina. Dzięki niemu szybciej można wykryć raka piersi

Polski projekt przyszłością diagnostyki onkologicznej

Szybki test nowotworowy

Rewolucja w diagnostyce raka piersi – mikrosonda InProbe

Naukowcy z Lublina opracowali rewolucyjną metodę wykrywania raka piersi

Rewolucja w diagnostyce raka nadciąga z Lublina

Lubelscy naukowcy opracowali szybszą metodę wykrywania raka piersi

Polski projekt przyszłością diagnostyki onkologicznej

Lubelski wykrywacz raka

To urządzenie sprawdzi w kwadrans, czy nowotwór jest złośliwy

SDS Optic zdobywcą nagrody Wschodzące Technologie

Polska medycyna sięga po dane

Nowe technologie ratują życie

Sonda z Lublina skróci wykrycie raka piersi do 15 minut. Nadzieja dla pacjentów

PARP – Go to Brand

SDS Optic was granted from PARP Go to Brand programme for inPROBE promotion actions on foreign markets. Main aim of this grant is supporting promotion and internationalization inPROBE project.

Each of the Go To Brand payee has a promotion funding programme which indicates specific events (usually trade shows) at non-EU markets, where companies may promote their products. Individual promotional activities are thus linked with the national strategy of building repute and prestige of the Polish economy brand abroad.

The Polish Agency for Enterprise Development (PARP) is involved in the implementation of national and international programmes financed from the EU structural funds, state budget and multiannual programmes of the European Commission. As a key authority responsible for creating a business-friendly environment in Poland, PARP contributes to the creation and effective implementation of the state policy related to enterprise, innovation and staff adaptability. Pursuant to the principle “Think Small First”, in all its activities the Agency puts a particular emphasis on the needs of the SME sector.

NCBiR Strategmed

The Programme intends to face challenges of ageing society, the higher incidence of chronic diseases and in the end, to deal with the issue of rising medical service costs.

The key objective of the Programme is to achieve a significant progress in the treatment of civilization diseases and regenerative medicine on the basis of results achieved from research and development activities conducted in the following areas:

  1. Cardiology and cardiac surgery
  2. Oncology
  3. Neurology and senses
  4. Regenerative medicine

The Programme is to stimulate the innovation and competitiveness of Polish economy, particularly in biotechnology, biomedical engineering areas, by means of projects oriented to development and implementation of new methods used in the areas of: prevention, diagnosis, medical treatment and rehabilitation.  

Moreover, STRATEGMED will strengthen the international competitive position of Poland in the following areas: research and development activities in the scientific fields related to STRATEGMED, involvement of dynamic international teams of young researches and finally, know-how and new technologies transfer to the Polish economy.

Horizon 2020 SME Instrument

The European Commission has contributed to SDS Optic’s project “Revolutionary opto-biological methodology for aggressive HER2 cancer”. The startup from Lublin was granted €3.985.000 from the SME Instrument (Horizon 2020) programme to develop a revolutionary optical device OmiProbe for safe, fast and non-destructive cancer diagnosis.

As part of the Horizon 2020 programme, the European Commission is hand-picking potentially disruptive businesses to invest and support as part of the SME Instrument. In the latest phase (June 2017), 1514 projects applied for the financial support and only 57 (2 from Poland) got funding. The grant for SDS Optic is so far the largest for the polish company and also the largest in this phase of the programme. It will finance optimisation of the SDS-OmiProbe device, independent clinical trials, certification and commercialisation.

SDS Optic designed a revolutionary opto-biological methodology that allows for instant cellular processes studies including in-vivo cancer diagnosis with single-cell resolution. SDS inProbe detects presence and measures concentration levels of the HER+ cancer cells in breast tumours. It is a breakthrough device that carries the potential to address the challenges of SoA cancer markers diagnosis and biopsies. In essence, it is a laboratory test at the tip of a probe, but with greater accuracy, efficacy and quantitative results. SDS-OmiProbe may also be used as a companion diagnostic tool for targeted therapy and targeted therapy drugs.

According to World Health Organization, cancer is one of the leading causes of morbidity and mortality worldwide, with approximately 14 million new cases per year. Breast cancer is the most common cancer among women and is considered the second most common cancer overall. Each year about 1.7 million new cases are diagnosed worldwide and over 500,000 women die from the disease. Current diagnosis methods of cancers fail to deliver objective results. Diagnosis requires extracting tissue samples via invasive and expensive biopsy, followed by laboratory analysis, which is subject to significant levels of discordance. Thanks to SDS-OmiProbe, the accurate result of the same analysis will be achievable in a few minutes. It will spare the patient’s pain and stress connected with biopsy and waiting for the results. It is planned that the first patients will be diagnosed using SDS inProbe in 2021.

Visit official website:


We believe that partnership is a important part of project success. SDS Optic recognize and value that collaboratively work can help us to improve our vision. We cooperate with experienced scientists, doctors, bio tech engineers and business specialists.The partnerships formed between interested science and medical institutions advance our mission and allow to make another step to future.

Warsaw University of Technology, Institute of Microelectronics and Optoelectronics

WARSAW UNIVERSITY OF TECHNOLOGY (WUT) is ranked as No. 1 among technical universities in Poland. There are 19 faculties, 2500 employed scientists, and over 33,000 students. Warsaw University of Technology builds upon the traditions of Polish technical universities that used to function in Warsaw. The Polytechnic Institute founded in 1826 thanks to the efforts of Stanisław Staszic and the School of Hipolit Wawelberg and Stanisław Rotwand established in 1895. Warsaw University of Technology started on its own in 1915 thanks to the efforts of the Association for Scientific Courses and the Citizens’ Committee of the City of Warsaw. Working uninterruptedly, the University has been producing generations of graduates and has had an increasing number of scientific and technical achievements. It is not only the oldest, but also the best technical university in Poland; in the ranking of Polish universities, it has taken the first place in its category for nine years. At Warsaw University of Technology, over 180 student research groups, organizations and associations are active, and the educational offer includes more than 30 fields of study (also with English as a medium of instruction).

Visit official website:

PORT Polish Center for Technology Development (former EIT+), Nanobioengeenering Laboratory

PORT Polish Center for Technology Development is a research and development organization focused on the development of new technologies by conducting research for the needs and in cooperation with the industry. PORT is a network of specialized scientific-research and technological laboratories as well as measurement and specialist laboratories, which are clustered in 6 research areas: biobank, biotechnology, nanobioengineering, special materials, photonics and electronics, analytics. Each of the areas brings together several specialized laboratories; thanks to this, a given area can focus on selected scientific and technological issues and carry out both scientific and research work as well as pilot research for industry in a comprehensive way. All laboratories of the PORT Polish Center for Technology Development are equipped with the highest-class research equipment which allows conducting application research while maintaining the highest quality standards.

Visit official website:

Clinmark CRO

Leading Polish Contract Research Organization. Clinmark conducts the full scope of operational activities in clinical research, professional consulting and education. Clinmark has operated since 2001 in Poland and other CEE markets. Clinmark has conducted more than 150 research projects in almost any therapeutical area. 8 out of top 10 worldwide pharmaceutical companies are their clients.

Visit official website:

Medical University of Lublin

The Medical University of Lublin was formed by the Cabinet’s decree on 24 October 1949. It conducts research tasks, educates students and doctoral candidates in the field of medical, pharmaceutical and health sciences. Moreover the University participates in exercising the medical care on the basis of self-contained public healthcare centers. The Medical University of Lublin is divided into four faculties: I Faculty of Medicine with Dentistry Division, II Faculty of Medicine with English Language Division, Faculty of Pharmacy with Medical Analytics Division and Faculty of Nursing and Health Sciences. Currently, almost 7.000 people, over 1.000 of whom are foreign students from as many as 53 countries, are enrolled on degree courses.

Visit official website:

University of Life Sciences in Lublin

The University of Life Sciences in Lublin is a multi-profile higher education institution, which integrates a wide range of agricultural, biological, veterinary, technical and socioeconomic sciences. Educational offer is attractive for the local secondary school leavers as new directions of studies are created to meet requirements of the current job market in Poland, the contents and forms of education comply with current educational standards. Well experienced academic staff and up-to-date didactic and research base guarantee high level of education approved by certificates.The 65-year-old activity of the University has shown its high rank in the structure of the Polish higher education system.

Visit official website:

Wroclaw Medical University

Wroclaw Medical University is currently the largest in Lower Silesian Voivodeship with over 100,000 graduates since 1945 including some 1,900 researchers among whom many received the highest awards for their contribution to the development of scientific scholarship.The University of Wrocław is renowned for its relatively high quality of teaching, placing 44th on the QS University Rankings: EECA 2016,and is located in the same campus as the former University of Breslau, which produced 9 Nobel Prize winners.

Visit official website:

Institute of Immunology and Experimental Therapy

Institute of Immunology and Experimental Therapy was founded in 1952 by the Polish Academy of Sciences. The main founder and the first director of the Institute was Professor Ludwik Hirszfeld, famous Polish immunologist and microbiologist.

Visit official website:

Lublin Medicine Cluster

Lublin Medicine – Medical & Wellness Cluster is a cooperation platform among higher education institutions, research centers, healthcare entities, entrepreneurs, institutions for collaboration and local authorities, Cluster was established in January 2014 by representatives of the City of Lublin and Medical University of Lublin. The aim of this initiative is to support local medical and wellness industries development.

Visit official website:

Amazonki Polish Foundation Against Breast Cancer

Amazonki mission is to help women now by providing help and inspiring hope to those affected by breast cancer through early detection, education and support services.

Visit official site:

Rak’n’Roll Foundation

Avon Against Breast

Our vision

Save 30% of people deadly sick with cancer by 2030

Our vision is to develop innovative cancer diagnostics & monitoring technologies which will help increase cancer survival by 30% by 2030. We will achieve that by implementing real-time, in vivo (closest possible to disease condition) and numerical based technologies. 

Strategy and mission

Our strategy is to discover, develop, produce and commercialize on a global scale unique innovative diagnostics and monitoring technologies working in real-time and in a natural state, which support and save Lifes.We respond to people living with serious cancer, autoimmune and dangerous fungal diseases as well as rare infectious conditions.We concentrate on helping the healthcare with faster, less painful diagnostics and supporting targeted, effective treatment procedures. Working with key collaborators we seek to develop and create high value applications that can bring innovative medicines to more people much faster, leading to improvements in health and longer lifetimes worldwide. SDS Optic’s mission is to create life saving innovations